Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2006-08-22
2006-08-22
Whisenant, Ethan (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S007100
Reexamination Certificate
active
07094533
ABSTRACT:
Presented is a therapeutic method to treat prostate carcinomas in mammals comprising the administration of cellular PAcP protein. Also presented is a method to diagnose androgen-insensitive prostate carcinomas by determining the expression level of cellular PAcP in the prostate carcinomas, a decrease in expression being indicative of androgen-insensitivity. A promoter region that is specifically expressed in prostate tissue is presented, as is a xenograft animal mode that mimics human prostate carcinomas in the expression of cellular PAcP.
REFERENCES:
patent: 5763202 (1998-06-01), Horoszewicz
Ostanin, K. et al., Heterologous Expression of Human Prostatic Acid Phosphatase and Site-directed Mutagenesis . . . , The Journal of Biological Chemistry, vol. 269, (Mar. 1994), pp. 8971-8978.
Porvari, K. et al., Differential androgen regulation of Rat Prostatic Acid Phosphatase Transcript., vol. 213, No. 3 pp. 861-868, (Aug. 1995).
Lilja, H. et al., “Three Predominant Proteins Secreted by the Human Prostate Gland”; The Prostate, 12: 29-38 (1988).
Banas, B. et al., “Analysis of the promoter of the human prostatic acid phosphatase gene”; Biochimica et Biophysica Acta 1217: 188-194 (1994).
Clarke, R. et al., “Progression of human breast cancer cells from hormone-dependent to hormone-independent growth bothin vitroandin vivo”; Proc. Natl. Acad. Sci., 86: 3649-3653 (1989).
Cleutjens, K.B.J.M. et al., “An Androgen Response Element in a Far Upstream Enhancer Region Is Essential for High, Androgen-Regulated Activity of the Prostate-Specific Antigen Promoter”; Molecular Endocrinology, vol. 11 No. 2, 148-161 (1997).
Cohen, P., “Classification of Protein-Serine/Threonine Phosphatases: Identification and Quantitation in Cell Extracts”; Methods in Enzymology, vol. 201, 389-398 (1991).
Culig, Z., et al., “DNA Sequence of the Androgen Receptor in Prostatic Tumor Cell Lines and Tissue Specimens Assessed by Means of the Polymerase Chain Reaction”; The Prostate, 22: 11-22 (1993).
Garcia-Arenas, R. et al., “The expression of prostatic acid phosphatase is transcriptionally regulated in human prostate carcinoma cells”; Molecular and Cellular Endrocrinology, 111: 29-37 (1995).
Gittes, R.F., “Carcinoma of the Prostate”; The New England Journal of Medicine, vol. 324, No. 4, 236-245 (1991).
Ghosh-Choudhury, G. et al., “Stable Transfer of a Mouse Dihydrofolate Reductase Gene into a Deficient Cell Line Using Human Adenovirus Vector”; Biochemical and Biophysical Research Communications, vol. 147, No. 3, 964-973 (1987).
Grayhack, J.T. et al., “Carcinoma of the Prostate, Hormonal Therapy”; Cancer 60: 589-601 (1987).
Gruppuso, P.A. et al., “Growth Arrest Induced by Transforming Growth Factor β1 Is Accompanied by Protein Phosphatase Activation in Human Keratinocytes”; The Journal of Biological Chemistry, vol. 266, No. 6, 3444-3448 (1991).
Langeler, E.G. et al., “Effect of Culture Conditions on Androgen Sensitivity of the Human Prostatic Cancer Cell Line LNCaP”; The Prostate 23: 213-223 (1993).
Li, H. et al., “A phosphotyrosyl-protein phosphatase activity associated with acid phosphatase from human prostate gland”; Eur. J. Biochem. 138: 45-51 (1984).
Lin, M. et al., “The Epidermal Growth Factor Receptor from Prostate Cells Is Dephosphorylated by a Prostate-Specific Phosphotyrosyl Phosphatase”; Molecular and Cellular Biology, vol. 8, No. 12, 5477-5485 (1988).
Lin, M. et al., “Human Prostatic Acid Phosphatase and Its Phosphotyrosyl-Protein Phosphatase Activity”; Adv. Prot. Phosphatases 4, 199-228 (1987).
Lin, M. et al., “Effect of cell density on androgen regulation of the mRNA level of human prostatic acid phosphatase”; Molecular and Cellular Endocrinology, 99: R21-R24 (1994).
Lin, M. et al., “Tyrosine Phosphorylation of a 185 kDa Phosphoprotein (pp. 185) Inversely Correlates with the Cellular Activity of Human Prostatic Acid Phosphatase”; Biochemical and Biophysical Research Communications, 226: 206-213 (1996).
Lin, M. et al., “Regulation of the Expression of Prostatic Acid Phosphatase in LNCaP Human Prostate Carcinoma Cells”; Cellular and Molecular Biology Research, vol. 39, No. 8, 739-750 (1993).
Lin, M. et al., “Growth Inhibition of Androgen-Insensitive Human Prostate Carcinoma Cells by a 19-Norsteroid Derivative Agent, Mifepristone”; The Prostate 26: 194-204 (1995).
Lin, M. et al., “Human prostatic acid phosphatase has phosphotyrosyl phosphatase activity”; Biochem. J., 235: 351-357 (1986).
Horoszewicz, J.S. et al., “LNCaP Model of Human Prostatic Carcinoma”; Cancer Research, 43: 1809-1818 (1983).
Lin, M. et al., “Tyrosyl Kinase Activity Is Inversely Related to Prostatic Acid Phosphatase Activity in Two Human Prostate Carcinoma Cell Lines”; Molecular and Cellular Biology, vol. 6., No. 12, 4753-4757 (1986).
Lin, M. et al., “Expression of Human Prostatic Acid Phosphatase Correlates with Androgen-stimulated Cell Proliferation in Prostate Cancer Cell Lines”; The Journal of Biological Chemistry, vol. 273, No. 10, 5939-5947 (1998).
Lin, M. et al., “The cellular level of prostatic acid phosphatase and the growth of human prostate carcinoma cells”; Differentiation, 57: 143-149 (1994).
Lin, M. et al., “Cationic Liposome-Mediated Incorporation of Prostatic Acid Phosphatase Protein Into Human Prostate Carcinoma Cells”; Biochemical and Biophysical Research Communications, vol. 192, No. 2, 413-419 (1993).
Lin, M. et al., “Regulation of Prostatic Acid Phosphatase Expression and Secretion by Androgen in LNCaP Human Prostate Carcinoma Cells”; Archives of Biochemistry and Biophysics, vol. 300, No. 1, 384-390 (1993).
Lin, M. et al., “Expression of Human Prostatic Acid Phosphatase Activity and the Growth of Prostate Carcinoma Cells”; Cancer Research, 52: 4600-4607 (1992).
Lin, M. et al., “Purification and Characterization of a New Human Prostatic Acid Phosphatase Isoenzyme”; Biochemistry, 22: 1055-1062 (1983).
Meng, T., “Tyrosine Phosphorylation of c-ErbB-2 Is Regulated by the Cellular Form of Prostatic Acid Phosphatase in Human Prostate Cancer Cells”; The Journal of Biological Chemistry, vol. 273, No. 34, 22096-22104 (1998).
Ostanin, K. et al., “Heterologous Expression of Human Prostatic Acid Phosphatase and Site-directed Mutagenesis of the Enzyme Active Site”; The Journal of Biochemical Chemistry, vol. 269, No. 12, 8971-8978 (1994).
Pang, S. et al., “Identification of a Positive Regulatory Element Responsible for Tissue-specific Expression of Prostate-specific Antigen”; Cancer Research, 57: 495-499 (1997).
Porvari, K. et al., “Differential Androgen Regulation of Rat Prostatic Acid Phosphatase Transcripts”; Biochemical and Biophysical Research Communications, vol. 213, No. 3, 861-868 (1995).
Ruizeveld De Winter, J.A. et al., “Androgen Receptor Heterogeneity in Human Prostatic Carcinomas Visualized by Immunohistochemistry”; Journal of Pathology, vol. 161: 329-332 (1990).
Sakai, H. et al., “Prostate Specific Antigen and Prostatic Acid Phosphatase Immunoreactivity as Prognostic Indicators of Advanced Prostatic Carcinoma”; The Journal of Urology, vol. 149, 1020-1023 (1993).
Schneider, G. et al., “Three-dimensional structure of rat acid phosphatase”; The EMBO Journal, vol. 12, No. 7, 2609-2615 (1993).
Shan, J. et al., “Steroid-Involved Transcriptional Regulation of Human Genes Encoding Prostatic Acid Phosphatase, Prostate-Specific Antigen, and Prostate-Specific Glandular Kallikrein”; Endocrinology, vol. 138, No. 9, 3764-3770 (1997).
Sharief, F.S. et al., “Nucleotide Sequence of Human Prostatic Acid Phosphatase ACPP Gene, Including Seven ALU Repeats”; Biochemistry and Molecular Biology International, vol. 33, No. 3, 561-565 (
Board of Regents of the University of Nebraska
Dann Dorfman Herrell and Skillman
Rigaut Kathleen D.
Whisenant Ethan
LandOfFree
Therapeutic and diagnostic applications of prostatic acid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic and diagnostic applications of prostatic acid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic and diagnostic applications of prostatic acid... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3632714